Nejib H Mekni

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Anti Inflammatory

Molecular Docking

Induced Pluripotent Stem Cells

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Lotfi M Aroua, Abdulelah H Alosaimi, Fahad M Alminderej, Sabri Messaoudi, Hamdoon A Mohammed, Suliman A Almahmoud, Sridevi Chigurupati, Abuzar E A E Albadri, Nejib H Mekni
Synthesis, Molecular Docking, and Bioactivity Study of Novel Hybrid Benzimidazole Urea Derivatives: A Promising α-Amylase and α-Glucosidase Inhibitor Candidate with Antioxidant Activity. Pharmaceutics 15 (2) (2023)
Lotfi M Aroua, Abdulelah H Alosaimi, Fahad M Alminderej, Sabri Messaoudi, Hamdoon A Mohammed, Suliman A Almahmoud, Sridevi Chigurupati, Abuzar E A E Albadri, Nejib H Mekni
Synthesis, Molecular Docking, and Bioactivity Study of Novel Hybrid Benzimidazole Urea Derivatives: A Promising α-Amylase and α-Glucosidase Inhibitor Candidate with Antioxidant Activity. Pharmaceutics 15 (2) (2023)
Lotfi M Aroua, Abdulelah H Alosaimi, Fahad M Alminderej, Sabri Messaoudi, Hamdoon A Mohammed, Suliman A Almahmoud, Sridevi Chigurupati, Abuzar E A E Albadri, Nejib H Mekni
Synthesis, Molecular Docking, and Bioactivity Study of Novel Hybrid Benzimidazole Urea Derivatives: A Promising α-Amylase and α-Glucosidase Inhibitor Candidate with Antioxidant Activity. Pharmaceutics 15 (2) (2023)
Lotfi M Aroua, Abdulelah H Alosaimi, Fahad M Alminderej, Sabri Messaoudi, Hamdoon A Mohammed, Suliman A Almahmoud, Sridevi Chigurupati, Abuzar E A E Albadri, Nejib H Mekni
Synthesis, Molecular Docking, and Bioactivity Study of Novel Hybrid Benzimidazole Urea Derivatives: A Promising α-Amylase and α-Glucosidase Inhibitor Candidate with Antioxidant Activity. Pharmaceutics 15 (2) (2023)